Cargando…

Loss of Hepatic Carcinoembryonic Antigen‐Related Cell Adhesion Molecule 1 Links Nonalcoholic Steatohepatitis to Atherosclerosis

Patients with nonalcoholic fatty liver disease/steatohepatitis (NAFLD/NASH) commonly develop atherosclerosis through a mechanism that is not well delineated. These diseases are associated with steatosis, inflammation, oxidative stress, and fibrosis. The role of insulin resistance in their pathogenes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghadieh, Hilda E., Abu Helal, Raghd, Muturi, Harrison T., Issa, Daniella D., Russo, Lucia, Abdallah, Simon L., Najjar, John A., Benencia, Fabian, Vazquez, Guillermo, Li, Wei, Najjar, Sonia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603529/ https://www.ncbi.nlm.nih.gov/pubmed/33163831 http://dx.doi.org/10.1002/hep4.1590

Ejemplares similares

SUN-079 Loss of Endothelial CEACAM1 Induces Atherogenic Fibrous Plaque Formation
por: Abu Helal, Raghd, et al.
Publicado: (2019)

SAT-174 Loss of CEACAM1 in Endothelial Cells Causes Hepatic Fibrogenesis
por: Muturi, Harrison, et al.
Publicado: (2019)

Aortic Fibrosis in Insulin-Sensitive Mice with Endothelial Cell-Specific Deletion of Ceacam1 Gene
por: Abu Helal, Raghd, et al.
Publicado: (2022)

Insulin Sensitivity Is Retained in Mice with Endothelial Loss of Carcinoembryonic Antigen Cell Adhesion Molecule 1
por: Muturi, Harrison T., et al.
Publicado: (2021)

Exenatide induces carcinoembryonic antigen‐related cell adhesion molecule 1 expression to prevent hepatic steatosis
por: Ghadieh, Hilda E., et al.
Publicado: (2017)

Reduced Hepatic Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Level in Obesity
por: Heinrich, Garrett, et al.
Publicado: (2017)

Editorial: Metabolism in nonalcoholic fatty liver disease
por: Najjar, Sonia Michael, et al.
Publicado: (2023)

Regulation of Insulin Clearance by Non-Esterified Fatty Acids
por: Najjar, Sonia M., et al.
Publicado: (2022)

Carcinoembryonic Cell Adhesion-Related Molecule 2 Regulates Insulin Secretion and Energy Balance
por: Salaheldeen, Elsaid, et al.
Publicado: (2019)

SAT-151 Hyperinsulinemia-Driven Progressive Metabolic Dysfunction in Male Mice with Liver-Specific CEACAM1 Deletion
por: Ghadieh, Hilda, et al.
Publicado: (2019)

Role of Insulin Clearance in Insulin Action and Metabolic Diseases
por: Ghadieh, Hilda E., et al.
Publicado: (2023)

Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene
por: Russo, Lucia, et al.
Publicado: (2018)

Mice with null mutation of Ceacam1 develop nonalcoholic steatohepatitis
por: Ghosh, Sumona, et al.
Publicado: (2010)

PSUN121 Nonalcoholic Steatohepatitis (NASH), Race/Ethnicity, and Gender in Adult US Population of NHANES 17-18
por: Friedman, Theodore, et al.
Publicado: (2022)

Chlorogenic acid/chromium supplement rescues diet-induced insulin resistance and obesity in mice
por: Ghadieh, Hilda E, et al.
Publicado: (2015)

Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease
por: Heinrich, Garrett, et al.
Publicado: (2017)

Prevalence and Predictors of Nonalcoholic Steatohepatitis Using Multiple Non-Invasive Methods: Data from NHANES III
por: Shaheen, Magda, et al.
Publicado: (2020)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

Cholesterol depletion decreases adhesion of non-small cell lung cancer cells to E-selectin
por: Mohammadalipour, Amina, et al.
Publicado: (2023)

Genome-Wide Association Studies Candidate Gene to Dual Modifier of Nonalcoholic Steatohepatitis and Atherosclerosis
por: Miller, Clint L., et al.
Publicado: (2016)

Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs
por: Galatou, Eleftheria, et al.
Publicado: (2022)

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1: A Link Between Insulin and Lipid Metabolism
por: DeAngelis, Anthony M., et al.
Publicado: (2008)

Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011)

Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012)

The Immune Landscape in Nonalcoholic Steatohepatitis
por: Narayanan, Sowmya, et al.
Publicado: (2016)

Betel Chewing and Nonalcoholic Steatohepatitis
por: Bleibel, Wissam, et al.
Publicado: (2018)

The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
por: Parthasarathy, Gopanandan, et al.
Publicado: (2020)

Insulinoma in Patient With Nonalcoholic Steatohepatitis
por: Cain, Daniel, et al.
Publicado: (2023)

Challenges and opportunities in nonalcoholic steatohepatitis
por: Wang, Xiaobo
Publicado: (2022)

Role of Oxidative Stress and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Nonalcoholic Fatty Liver Disease
por: Memaj, Plator, et al.
Publicado: (2023)

Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis
por: Kushiyama, Akifumi, et al.
Publicado: (2016)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Wilson's disease masquerading as nonalcoholic steatohepatitis
por: Mahmood, Sabina, et al.
Publicado: (2009)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
por: Lam, Mindy C.W., et al.
Publicado: (2012)

The effect of β-caryophyllene on nonalcoholic steatohepatitis
por: Arizuka, Naoya, et al.
Publicado: (2017)

New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
por: Mendez-Sanchez, Nahum, et al.
Publicado: (2018)

Repurposing drugs to target nonalcoholic steatohepatitis
por: Sookoian, Silvia, et al.
Publicado: (2019)

The regulatory state of nonalcoholic steatohepatitis and metabolism
por: Omokaro, Stephanie O., et al.
Publicado: (2020)

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis
por: Sumida, Yoshio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oltffffbif6bnsbas57r66p0qr